tetracaine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
local anaesthetics 2610 94-24-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • tetracaine monohydrochloride
  • pontocaine
  • tetracaine
  • amethocaine
  • laudocaine
  • tetracaine hydrochloride
  • tetracaine HCl
Local ester anesthetic that blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.
  • Molecular weight: 264.37
  • Formula: C15H24N2O2
  • CLOGP: 3.83
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 1
  • TPSA: 41.57
  • ALOGS: -2.68
  • ROTB: 9
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
June 23, 2005 FDA GALEN SPECIALTY

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxic anterior segment syndrome 145.85 44.82 24 715 1747 63486536
Aqueous fibrin 92.65 44.82 11 728 66 63488217
Endophthalmitis 79.37 44.82 16 723 3576 63484707
Suspected transmission of an infectious agent via product 53.89 44.82 8 731 294 63487989
Visual acuity reduced 46.58 44.82 15 724 21811 63466472

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxic anterior segment syndrome 203.73 49.55 33 714 2731 79740910
Aqueous fibrin 106.92 49.55 13 734 125 79743516
Suspected transmission of an infectious agent via product 93.28 49.55 15 732 1171 79742470
Endophthalmitis 84.88 49.55 18 729 6410 79737231

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C05AD02 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Local anesthetics
ATC D04AB06 DERMATOLOGICALS
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
Anesthetics for topical use
ATC N01BA03 NERVOUS SYSTEM
ANESTHETICS
ANESTHETICS, LOCAL
Esters of aminobenzoic acid
ATC N01BA53 NERVOUS SYSTEM
ANESTHETICS
ANESTHETICS, LOCAL
Esters of aminobenzoic acid
ATC S01HA03 SENSORY ORGANS
OPHTHALMOLOGICALS
LOCAL ANESTHETICS
Local anesthetics
FDA CS M0007766 Esters
MeSH PA D000777 Anesthetics
MeSH PA D000779 Anesthetics, Local
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D018689 Sensory System Agents
CHEBI has role CHEBI:36333 local anesthetics
FDA EPC N0000175683 Ester Local Anesthetic
FDA PE N0000175976 Local Anesthesia

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Local anesthetic intrathecal block indication 231249005
Skin irritation indication 367466007
Local anesthesia indication 386761002
Itching of skin indication 418363000
Minor Skin Wound Pain indication
Local Anesthesia for Ophthalmologic Procedure indication
Administration of Corneal Anesthesia indication
Hyperthyroidism contraindication 34486009 DOID:7998
Conduction disorder of the heart contraindication 44808001
Disorder of cardiovascular system contraindication 49601007 DOID:1287
Heart disease contraindication 56265001 DOID:114
Decreased respiratory function contraindication 80954004
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Magnetic resonance imaging contraindication 113091000
Open wound contraindication 125643001
Eye infection contraindication 128351009
Uveitis contraindication 128473001 DOID:13141
Seizure disorder contraindication 128613002
Disease of liver contraindication 235856003 DOID:409
Deficiency of cholinesterase contraindication 360607009
Denuded skin contraindication 418242004




🐶 Veterinary Drug Use

SpeciesUseRelation
Cats Acute otitis externa Indication
Cats Chronic otitis externa Indication
Cats Ear canker Indication
Cats Inflammatory conditions of the external ear canal Indication
Cats Dressing for minor cuts, lacerations, abrasions, and post-surgical therapy Indication
Cats Following amputation of dewclaw Indication
Cats Following amputation of tails and claws Indication
Cats Following ear trimming Indication
Cats Following castrating operations Indication
Dogs Acute otitis externa Indication
Dogs Chronic otitis externa Indication
Dogs Ear canker Indication
Dogs Inflammatory conditions of the external ear canal Indication
Dogs Following amputation of dewclaw Indication
Dogs Following amputation of tails and claws Indication
Dogs Following ear trimming Indication
Dogs Following castrating operations Indication
Horses Superficial dressing applied to minor cuts Indication
Horses Pain after post-surgery Indication
Horses Superficial dressing applied to wounds Indication
Horses Superficial dressing applied to lacerations Indication
Horses Superficial dressing applied to abrasions Indication

🐶 Veterinary products

ProductApplicantIngredients
Neo-Cortef with Tetracaine Zoetis Inc. 3
Neo-Delta-Cortef with Tetracaine Ointment Zoetis Inc. 3
Neo-Predef with Tetracaine Powder Zoetis Inc. 3
Neo-Predef with Tetracaine Top. Ointment, Tritop Topical Ointment Zoetis Inc. 3

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 8.51 Basic
pKa2 2.67 Basic

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
0.1MG/SPRAY;6MG/SPRAY KOVANAZE ST RENATUS N208032 June 29, 2016 RX SPRAY, METERED NASAL 8580282 April 2, 2030 METHOD OF ANESTHETIZING AT LEAST A PORTION OF THE MAXILLARY DENTAL ARCH
0.1MG/SPRAY;6MG/SPRAY KOVANAZE ST RENATUS N208032 June 29, 2016 RX SPRAY, METERED NASAL 9308191 April 2, 2030 METHOD OF ANESTHETIZING AT LEAST A PORTION OF THE MAXILLARY DENTAL ARCH

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Sodium channel protein type 5 subunit alpha Ion channel BLOCKER IC50 6.28 CHEMBL CHEMBL
Sodium channel protein type 2 subunit alpha Ion channel BLOCKER IC50 5.96 CHEMBL CHEMBL
Sodium channel protein type 9 subunit alpha Ion channel BLOCKER Ki 6.30 CHEMBL CHEMBL
Sodium channel alpha subunits; brain (Types I, II, III) Ion channel BLOCKER IC50 5.47 CHEMBL CHEMBL
Sodium channel protein type 8 subunit alpha Ion channel IC50 6.28 CHEMBL
Amine oxidase [flavin-containing] A Enzyme IC50 6.50 DRUG MATRIX
Sodium channel protein type 7 subunit alpha Ion channel IC50 7.25 CHEMBL
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 6.15 DRUG MATRIX
5-hydroxytryptamine receptor 2A GPCR Ki 6.01 DRUG MATRIX
5-hydroxytryptamine receptor 2C GPCR Ki 5.77 DRUG MATRIX
cGMP-gated cation channel alpha-1 Ion channel Kd 5.17 CHEMBL
Sodium channel alpha subunits; brain (Types I, II, III) Ion channel IC50 5.22 CHEMBL

External reference:

IDSource
4019456 VUID
N0000147578 NUI
D00551 KEGG_DRUG
136-47-0 SECONDARY_CAS_RN
4018254 VANDF
4019456 VANDF
C0039629 UMLSCUI
CHEBI:9468 CHEBI
TE4 PDB_CHEM_ID
CHEMBL698 ChEMBL_ID
DB09085 DRUGBANK_ID
CHEMBL1255654 ChEMBL_ID
D013748 MESH_DESCRIPTOR_UI
5411 PUBCHEM_CID
431 INN_ID
0619F35CGV UNII
10391 RXNORM
177214 MMSL
5559 MMSL
5560 MMSL
59765 MMSL
5987 MMSL
80869 MMSL
d01217 MMSL
001361 NDDF
001362 NDDF
387309008 SNOMEDCT_US
51844001 SNOMEDCT_US
55556000 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0065-0741 SOLUTION 5 mg OPHTHALMIC NDA 24 sections
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0065-0741 SOLUTION 5 mg OPHTHALMIC NDA 24 sections
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0065-0741 SOLUTION 5 mg OPHTHALMIC NDA 24 sections
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0187-0920 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 24 sections
Cetacaine Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0201 AEROSOL, SPRAY 0.00 g TOPICAL UNAPPROVED DRUG OTHER 12 sections
Cetacaine Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0202 SOLUTION 0.00 g TOPICAL UNAPPROVED DRUG OTHER 12 sections
Cetacaine Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0202 SOLUTION 0.00 g TOPICAL UNAPPROVED DRUG OTHER 12 sections
Cetacaine Topical Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0217 GEL 0.00 g TOPICAL UNAPPROVED DRUG OTHER 11 sections
Cetacaine Topical Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0221 GEL 0.00 g TOPICAL UNAPPROVED DRUG OTHER 11 sections
Cetacaine Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0225 SOLUTION 0.00 g TOPICAL UNAPPROVED DRUG OTHER 12 sections
Cetacaine Anesthetic HUMAN PRESCRIPTION DRUG LABEL 3 10223-0226 SOLUTION 0.00 g TOPICAL UNAPPROVED DRUG OTHER 12 sections
Synera HUMAN PRESCRIPTION DRUG LABEL 2 10885-002 PATCH 70 mg CUTANEOUS NDA 26 sections
Tetracaine HUMAN PRESCRIPTION DRUG LABEL 1 17478-045 INJECTION 10 mg SUBARACHNOID unapproved drug other 19 sections
Tetracaine HUMAN PRESCRIPTION DRUG LABEL 1 17478-045 INJECTION 10 mg SUBARACHNOID unapproved drug other 19 sections
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 24208-092 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 25 sections
Burn Cream HUMAN OTC DRUG LABEL 1 37945-212 CREAM 10 mg TOPICAL OTC monograph not final 11 sections
Tetracaine HUMAN PRESCRIPTION DRUG LABEL 1 42494-437 INJECTION 10 mg ORAL Unapproved drug other 17 sections
Tetracaine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 42702-170 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 24 sections
Cutiecaine HUMAN OTC DRUG LABEL 2 50876-182 CREAM 20 mg TOPICAL OTC monograph not final 10 sections
PLIAGLIS HUMAN PRESCRIPTION DRUG LABEL 2 51672-5305 CREAM 70 mg TOPICAL NDA 28 sections
Tetracaine HCL HUMAN PRESCRIPTION DRUG LABEL 1 54288-127 INJECTION 10 mg SUBARACHNOID unapproved drug other 11 sections
Tetracaine HCL HUMAN PRESCRIPTION DRUG LABEL 1 54288-127 INJECTION 10 mg SUBARACHNOID unapproved drug other 11 sections
FranklyNumb 3 HUMAN OTC DRUG LABEL 1 54723-004 CREAM 2 g TOPICAL OTC monograph not final 9 sections
Inderma MD HUMAN OTC DRUG LABEL 1 54723-011 CREAM 2 g TOPICAL OTC monograph not final 9 sections
PENICHILLIN HUMAN OTC DRUG LABEL 1 54723-014 CREAM 2 g TOPICAL OTC monograph not final 9 sections
NeuroMed Topical AnalgesicLA HUMAN OTC DRUG LABEL 1 54723-310 CREAM 20 mg TOPICAL OTC monograph not final 12 sections
Eclipse Topical AnalgesicLL HUMAN OTC DRUG LABEL 1 54723-669 CREAM 20 mg TOPICAL OTC monograph not final 11 sections
Eclipse Topical AnalgesicLL HUMAN OTC DRUG LABEL 1 54723-669 CREAM 20 mg TOPICAL OTC monograph not final 11 sections
Eclipse Topical AnalgesicLL HUMAN OTC DRUG LABEL 1 54723-669 CREAM 20 mg TOPICAL OTC monograph not final 11 sections
Comfortox Tetracaine HUMAN OTC DRUG LABEL 1 54723-997 CREAM 20 mg TOPICAL OTC monograph not final 11 sections